Clinical evaluation of tafluprost and travoprost in Japanese patients with primary open angle glaucoma or ocular hypertension: multicenter, randomized, 12-week crossover study
- Conditions
- Primary open angle glaucoma or ocular hypertension
- Registration Number
- JPRN-UMIN000006621
- Lead Sponsor
- Hiroshima uiversity
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 220
Not provided
1. Patinets who with a history of allergy (i.e. hypersensitivity) to the drugs to be used during the study period. 2. Females who are pregnant, nursing or planning a pregnancy, or females of childbearing potential. 3. Patients who with a history of corneal refractive surgery. 4. Patinets who need wearing contact lenses during the study period. 5. Patinets who with extraocular disease, inflammation or infection in the eye(s) or eyelid(s). 6. Patinets who with a history of cataract surgery within 12 months. 7. Patinets who with a history of intraocular surgery including ocular laser treatment against glaucoma within 12 months 8. Patinets who has been treated with prostaglandin/timolol malate fixed combination. 9. Patinets who has been treated with prostaglandin generic drug. 10. Patinets who is treated dry eye therapy (drug medication, punctum plug and punctum occlusion). 11. Patinets who the investigator consider ineligible for enrolment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method